StreetAlpha
13F holdings · Q3 2026

Knoll Capital Management

Miami, FL · files as Knoll Capital Management, LLC
Know the moment Knoll Capital Management filesYou follow Knoll Capital Management An email or push as soon as its next 13F reaches the SEC, with every stock it bought, sold and trimmed. Next 13F due by Feb 15, 2027
Filed
Holdings as of Sep 30, 2026Filed Nov 16, 2026Next filing due Feb 15, 2027CIK 1325083

Knoll Capital Management reported 37 stocks worth $208M in its 13F filing for Q3 2026, filed Nov 16, 2026. Its largest holdings are Biohaven Pharmactl Hldg Co L (16.2%), ENTX (8.2%) and MGTX (6.6%). Compared with Q2 2026, the fund opened new positions in KZIA and MREO, added to WPM and VMET, trimmed ENTX and PHYS and sold out of ABEO and ALT.

Latest filing: what Knoll Capital Management did in Q3 2026

vs Q2 2026
Filed 13F-HRView on SEC ↗
2 new3 added2 trimmed2 sold outBought about $8.2M · sold about $9.7M
New 2
Added 3
  • WPM+$3.6M+213%
  • Biohaven Pharmactl+$2.3M+7%
  • VMET+$485K+83%
Trimmed 2
Sold out 2

Dollar changes use the share change at the quarter end price. New and sold out show the whole position.

Reported value$208M+16.2% vs last quarter
Stocks held372 new · 2 sold out
Top 5 weight41.6%fairly concentrated
Turnover9%of the portfolio changed

Portfolio at a glance

share of reported value · Q3 2026
🔒 A free account shows every holding, what the fund sold and its options.Create free account

Holdings

#StockValueWeightSharesChangeShares, 8 qtrsHeld
1
Biohaven Pharmactl Hldg Co L
$33.8M16.2%2.5M+174K (+7%)8 of 8
2
ENTX
Entera Bio Ltd
$17M8.2%5.8M−50K (−1%)8 of 8
3
MGTX
Meiragtx Hldgs PLC
$13.8M6.6%1.3MNo change8 of 8
4
RGLD
Royal Gold Inc
$12.4M6.0%53KNo change8 of 8
5
AEM
Agnico Eagle Mines Ltd F
$9.7M4.6%53KNo change8 of 8
6
SA
Seabridge Gold Inc
$9M4.3%317KNo change8 of 8
7
NUVB
Nuvation Bio Inc
$9M4.3%1.6MNo change7 of 8
8
OCUL
Ocular Therapeutix Inc
$8.8M4.2%1.2MNo change8 of 8
9
SSRM
Ssr Mining in
$8.2M3.9%245KNo change4 of 8
10
CGAU
Centerra Gold Inc
$7.8M3.8%359KNo change6 of 8
🔒 27 more holdings in this filing. Create a free account or sign in to see them all.

Positions at Sep 30, 2026, as reported. Change is against the fund's Q2 2026 filing; weight is the share of the fund's reported stocks.

Sold out

held in Q2 2026, gone in Q3 2026
StockValue last quarterShares sold
ABEO
Abeona Therapeutics Inc
$3M486K
ALT
Altimmune Inc
$486K160K

Reported value

last 8 quarters
$155MQ4 '24
$154MQ1 '25
$149MQ2 '25
$187MQ3 '25
$218MQ4 '25
$189MQ1 '26
$179MQ2 '26
$208MQ3 '26

The value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.

Filings for Q3 2026

straight from the SEC
FiledFormQuarter
Nov 16, 202613F-HRQ3 2026SEC filing ↗

Other superinvestors

All hedge fund holdings →

Knoll Capital Management 13F FAQ

What does Knoll Capital Management own?

Knoll Capital Management reported 37 stocks worth $208M in its 13F filing for Q3 2026, filed Nov 16, 2026. Its largest holdings are Biohaven Pharmactl Hldg Co L (16.2%), ENTX (8.2%) and MGTX (6.6%). The table above lists every position in the filing (the top 10 without an account).

What did Knoll Capital Management buy and sell in Q3 2026?

Compared with Q2 2026: 2 new positions, 3 added to, 2 trimmed and 2 sold out. New positions include KZIA and MREO. It sold all of ABEO and ALT.

When will Knoll Capital Management file its next 13F?

Holdings as of Dec 31, 2026 are due by Feb 15, 2027. The filing appears on this page within minutes of reaching the SEC.

How much is Knoll Capital Management's portfolio worth?

The Q3 2026 filing reports $208M in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.

For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.